These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37845743)

  • 21. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.
    Valiyaveettil M; Kar N; Ashraf MZ; Byzova TV; Febbraio M; Podrez EA
    Blood; 2008 Feb; 111(4):1962-71. PubMed ID: 17993610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages.
    Rios FJ; Gidlund M; Jancar S
    Cell Physiol Biochem; 2011; 27(3-4):363-72. PubMed ID: 21471725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events.
    Singh P; Goncalves I; Tengryd C; Nitulescu M; Persson AF; To F; Bengtsson E; Volkov P; Orho-Melander M; Nilsson J; Edsfeldt A
    Cardiovasc Diabetol; 2020 Dec; 19(1):214. PubMed ID: 33317535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD36 is a receptor for oxidized low density lipoprotein.
    Endemann G; Stanton LW; Madden KS; Bryant CM; White RT; Protter AA
    J Biol Chem; 1993 Jun; 268(16):11811-6. PubMed ID: 7685021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36.
    Han J; Hajjar DP; Febbraio M; Nicholson AC
    J Biol Chem; 1997 Aug; 272(34):21654-9. PubMed ID: 9261189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: Diabetes affects CD36 and oxLDL uptake.
    Kanoke A; Nishijima Y; Ljungberg M; Omodaka S; Yang SY; Wong S; Rabiller G; Tominaga T; Hsieh CL; Liu J
    Exp Neurol; 2020 Dec; 334():113461. PubMed ID: 32926860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.
    Uittenbogaard A; Shaul PW; Yuhanna IS; Blair A; Smart EJ
    J Biol Chem; 2000 Apr; 275(15):11278-83. PubMed ID: 10753938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.
    Bombeli T; Schwartz BR; Harlan JM
    J Exp Med; 1998 Feb; 187(3):329-39. PubMed ID: 9449713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions.
    Srikanthan S; Li W; Silverstein RL; McIntyre TM
    J Thromb Haemost; 2014 Nov; 12(11):1906-17. PubMed ID: 25163645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets directly enhance neutrophil transmigration in response to oxidised low-density lipoprotein.
    Badrnya S; Butler LM; Söderberg-Naucler C; Volf I; Assinger A
    Thromb Haemost; 2012 Oct; 108(4):719-29. PubMed ID: 22836389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion.
    Stewart BW; Nagarajan S
    Mol Immunol; 2006 Feb; 43(3):255-67. PubMed ID: 16199262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
    Guy RA; Maguire GF; Crandall I; Connelly PW; Kain KC
    Atherosclerosis; 2001 Mar; 155(1):19-28. PubMed ID: 11223422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo--brief report.
    Stellos K; Sauter R; Fahrleitner M; Grimm J; Stakos D; Emschermann F; Panagiota V; Gnerlich S; Perk A; Schönberger T; Bigalke B; Langer HF; Gawaz M
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2017-20. PubMed ID: 22701021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.
    Wang H; Wang ZH; Kong J; Yang MY; Jiang GH; Wang XP; Zhong M; Zhang Y; Deng JT; Zhang W
    Mol Med; 2012 Mar; 18(1):159-66. PubMed ID: 22064971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in macrophages.
    Li J; Yu C; Wang R; Xu J; Chi Y; Qin J; Liu Q
    Int J Biochem Cell Biol; 2017 Sep; 90():121-135. PubMed ID: 28789920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.
    Chen K; Li W; Major J; Rahaman SO; Febbraio M; Silverstein RL
    Blood; 2011 May; 117(21):5744-50. PubMed ID: 21427288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel role for CD36 in VLDL-enhanced platelet activation.
    Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
    Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROS Promote Ox-LDL-Induced Platelet Activation by Up-Regulating Autophagy Through the Inhibition of the PI3K/AKT/mTOR Pathway.
    Wang X; Fu YF; Liu X; Feng G; Xiong D; Mu GF; Chen FP
    Cell Physiol Biochem; 2018; 50(5):1779-1793. PubMed ID: 30384368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia.
    Yang M; Li W; Harberg C; Chen W; Yue H; Ferreira RB; Wynia-Smith SL; Carroll KS; Zielonka J; Flaumenhaft R; Silverstein RL; Smith BC
    Blood Adv; 2020 Sep; 4(18):4494-4507. PubMed ID: 32946569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.
    Hoosdally SJ; Andress EJ; Wooding C; Martin CA; Linton KJ
    J Biol Chem; 2009 Jun; 284(24):16277-16288. PubMed ID: 19369259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.